Launched by the pan-European exchange group in 2022, the Euronext Tech Leaders initiative brings together a select group of companies recognized for their innovation, growth profile, and contribution to the European tech ecosystem.

Members benefit from increased exposure to international investors, access to a broad network of market participants, and participation in a range of events and initiatives designed to support their long-term growth.

For Nanobiotix, joining the Euronext Tech Leaders segment reflects its position 'at the intersection of nanotechnology, physics, and medicine, as it develops a portfolio of physics-based nanotherapeutic platforms'.

'Our entry into the Euronext Tech Leaders segment recognizes not only the progress we have made as a company, but also the broader potential of physics-based innovation to contribute significantly to the future of healthcare,' commented Laurent Levy, co-founder and Chairman of the Executive Board.